Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,554,516
-
Share change
-
+135,147
-
Total reported value
-
$1,957,226
-
Price per share
-
$1.26
-
Number of holders
-
21
-
Value change
-
+$166,657
-
Number of buys
-
15
-
Number of sells
-
7
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q2 2022
As of 30 Jun 2022,
ACER THERAPEUTICS INC - COM (ACER) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,554,516 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Copperwynd Financial, LLC, CITADEL ADVISORS LLC, and NORTHERN TRUST CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.